VanEck Pharmaceutical ETF closed at $111.48 on Sep 28, up 0.12%, 5.4% below its 52-week closing high. Volume of 499.7K shares was 2.03× its 20-day average (well above normal).
Split-adjusted performance: -2.3% over one month, +10.4% over six months, +29.6% over one year.
Short interest was 2.5M shares at the Sep 15 settlement (11.5 days to cover).
Yes. The latest regular dividend was $0.6248 per share (ex-date Jul 1), an annualised yield of 2.24%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology